Abiraterone is effective and should be considered for the treatment of metastatic castrate-naïve prostate cancer.

Authors

Jacob M Elkon
Ralph L Millett
Kristin F Millado
Jianqing Lin, George Washington University

Document Type

Journal Article

Publication Date

3-1-2018

Journal

Expert opinion on pharmacotherapy

DOI

10.1080/14656566.2018.1444028

APA Citation

Elkon, J., Millett, R., Millado, K., & Lin, J. (2018). Abiraterone is effective and should be considered for the treatment of metastatic castrate-naïve prostate cancer.. Expert opinion on pharmacotherapy, (). http://dx.doi.org/10.1080/14656566.2018.1444028

Peer Reviewed

1